- General Electric is said to have filed for an initial public offering of its health unit, a spin-off that would create one of the world’s largest health giants.
- Bloomberg reported that the IPO would be publicly filed in the spring and that the new business would have an estimated enterprise value of $US65 billion to $US70 billion.
- The industrial conglomerate is reportedly working with Goldman Sachs, Bank of America, Citigroup, JPMorgan, and Morgan Stanley on the IPO plans.
General Electric has filed confidentially for an initial public offering of its health unit in a spin-off that would create one of the world’s largest pharma giants.
That’s according to Bloomberg, which, citing people familiar with the matter, said GE was likely to publicly file in the spring. Bloomberg calculates that the newly spun-off health company could have an enterprise value of $US65 billion to $US70 billion.
Enterprise value is typically calculated by adding market cap and debt, among other things, and subtracting cash.
Germany’s Siemens listed its Healthineers unit in March, and its shares are up about 32% since, Bloomberg said, making it a 37 billion euro company. GE is working with Goldman Sachs, Bank of America, Citigroup, JPMorgan, and Morgan Stanley on its IPO plans, Bloomberg reported.
GE’s stock was up about 1.2% in premarket trading Wednesday, hitting $US7.37 a share.
In other pharma news, GlaxoSmithKline and Pfizer on Wednesday said they were combining their consumer-health units in a venture valued at about 10 billion pounds, according to the Financial Times.
NOW WATCH: Money & Markets videos
Business Insider Emails & Alerts
Site highlights each day to your inbox.